A detailed history of D. E. Shaw & Co., Inc. transactions in Atrion Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 7,128 shares of ATRI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,128
Holding current value
$0
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$381.09 - $495.99 $2.72 Million - $3.54 Million
7,128 New
7,128 $3.22 Million
Q4 2023

Feb 14, 2024

BUY
$289.29 - $409.7 $28,929 - $40,970
100 Added 17.06%
686 $259,000
Q1 2022

May 16, 2022

SELL
$601.4 - $763.0 $10,825 - $13,734
-18 Reduced 2.98%
586 $418,000
Q4 2021

Feb 14, 2022

BUY
$650.15 - $802.0 $5,201 - $6,416
8 Added 1.34%
604 $426,000
Q3 2021

Nov 15, 2021

SELL
$594.24 - $758.0 $102,209 - $130,376
-172 Reduced 22.4%
596 $416,000
Q2 2021

Aug 16, 2021

BUY
$582.88 - $670.99 $58,288 - $67,099
100 Added 14.97%
768 $477,000
Q1 2021

May 17, 2021

SELL
$619.2 - $736.0 $16,099 - $19,136
-26 Reduced 3.75%
668 $428,000
Q3 2020

Nov 16, 2020

BUY
$620.1 - $689.89 $55,809 - $62,090
90 Added 14.9%
694 $434,000
Q2 2020

Aug 14, 2020

SELL
$610.05 - $713.9 $46,363 - $54,256
-76 Reduced 11.18%
604 $385,000
Q1 2020

May 15, 2020

SELL
$615.5 - $751.4 $98,480 - $120,224
-160 Reduced 19.05%
680 $442,000
Q4 2019

Feb 14, 2020

SELL
$688.5 - $846.15 $395,887 - $486,536
-575 Reduced 40.64%
840 $631,000
Q3 2019

Nov 14, 2019

BUY
$722.04 - $840.0 $1.02 Million - $1.19 Million
1,415 New
1,415 $1.1 Million
Q4 2018

Feb 14, 2019

SELL
$667.94 - $785.7 $257,156 - $302,494
-385 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$602.8 - $699.6 $1,808 - $2,098
3 Added 0.79%
385 $267,000
Q2 2018

Aug 14, 2018

SELL
$568.25 - $635.8 $50,574 - $56,586
-89 Reduced 18.9%
382 $229,000
Q1 2018

May 15, 2018

BUY
$526.8 - $633.85 $248,122 - $298,543
471 New
471 $297,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.